Delivering the Diabetes Remission Clinical Trial (DiRECT) in primary care: Experiences of healthcare professionals.


Journal

Diabetic medicine : a journal of the British Diabetic Association
ISSN: 1464-5491
Titre abrégé: Diabet Med
Pays: England
ID NLM: 8500858

Informations de publication

Date de publication:
03 2022
Historique:
received: 21 05 2021
accepted: 25 11 2021
pubmed: 28 11 2021
medline: 23 3 2022
entrez: 27 11 2021
Statut: ppublish

Résumé

The Diabetes Remission Clinical Trial (DiRECT) used a formula total diet replacement programme followed by structured weight loss maintenance to induce and sustain weight loss and remission of type 2 diabetes (T2D) in 36% of participants after 2 years. Nurses and dietitians delivering DiRECT in 22 primary care practices in Tyneside and Scotland provided behavioural support to participants. Participant experiences with DiRECT highlighted the key role of support by healthcare professionals (HCPs). We evaluated HCPs' experiences with DiRECT. Healthcare professionals delivering DiRECT were interviewed at 12 months, while general practices (GPs) were sent an implementation questionnaire. The interviews were analysed thematically. The questionnaires were analysed using frequencies and a narrative synthesis. Healthcare professionals representing 11 of 22 intervention practices were interviewed and 10 of 22 GPs completed questionnaires. HCPs' initial concerns over perceived potential negative intervention effects, particularly withdrawing anti-diabetes and anti-hypertensive medications, were barriers to engagement. Trust of HCPs towards the research team and perceived credibility of the study facilitated engagement and adoption. Ongoing support by research dietitians was key to the management of participants. Involvement in DiRECT inspired more focus on behaviour modification in the treatment of other people living with T2D in routine practice. Diabetes Remission Clinical Trial was considered highly appropriate for the management of T2D in primary care when supported by trained dietitians. Addressing limitations, including varying training needs of HCPs may improve intervention scale-up and tailoring to clinical contexts.

Identifiants

pubmed: 34837259
doi: 10.1111/dme.14752
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14752

Informations de copyright

© 2021 Diabetes UK.

Références

Lean MEJ, Leslie WS, Barnes AC, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018;391:541-551.
Lean MEJ, Leslie WS, Barnes AC, et al. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol. 2019;7:344-355.
Taheri S, Zaghloul H, Chagoury O, et al. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol. 2020;8:477-489.
Leslie WS, Ford I, Sattar N, et al. The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial. BMC Fam Pract. 2016;17:20.
NHS Choices. Very low calorie diets part of NHS action to tackle growing obesity and type 2 diabetes epidemic. Accessed March 26, 2021. https://www.england.nhs.uk/2018/11/very-low-calorie-diets-part-of-nhs-action-to-tackle-growing-obesity-and-type-2-diabetes-epidemic/
Scottish Government. Scottish Indices of Multiple Deprivation. 2015.
Hopkins M, Andrews R, Salem V, et al. Improving understanding of type 2 diabetes remission: research recommendations from Diabetes UK’s 2019 remission workshop. Diabet Med. 2020;37:1944-1950.
Rehackova L, Rodrigues AM, Thom G, et al. Participant experiences in the Diabetes Remission Clinical Trial (DiRECT). Diabet Med. 2021. doi:10.1111/dme.14689
Taylor R, Leslie WS, Barnes AC, et al. Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort. Diabetologia. 2018;61:589-598.
NICE. Obesity: identification, assessment and management. 2014. Accessed February 20, 2021. https://www.nice.org.uk/guidance/CG189
SIGN. Management of obesity No 115. 2010. Accessed February 20, 2021. https://www.sign.ac.uk/assets/qrg115.pdf
QSR International Pty Ltd. NVivo Qualitative Data Analysis Software 12. Pro Ed; 2020.
Sealed Envelope. Randomisation and online databases for clinical trials; 2017. Accessed December 10, 2021. https://www.sealedenvelope.com/
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77-101.
Krass I, Schieback P, Dhippayom T. Adherence to diabetes medication: a systematic review. Diabet Med. 2015;32:725-737.
McSharry J, McGowan L, Farmer AJ, et al. Perceptions and experiences of taking oral medications for the treatment of type 2 diabetes mellitus: a systematic review and meta-synthesis of qualitative studies. Diabet Med. 2016;33:1330-1338.
Rehackova L, Araújo-Soares V, Adamson AJ, et al. Acceptability of a very-low-energy diet in type 2 diabetes: patient experiences and behaviour regulation. Diabet Med. 2017;34:1554-1567.
Brundisini F, Vanstone M, Hulan D, et al. Type 2 diabetes patients’ and providers’ differing perspectives on medication nonadherence: a qualitative meta-synthesis. BMC Health Serv Res. 2015;15:516.
Astbury NM, Albury C, Nourse R, et al. Participant experiences of a low-energy total diet replacement programme: a descriptive qualitative study. PLoS One. 2020;15:e0238645.
Kempf K, Röhling M, Niedermeier K, et al. Individualized meal replacement therapy improves clinically relevant long-term glycemic control in poorly controlled type 2 diabetes patients. Nutrients. 2018;10:1022.
Rehackova L, Arnott B, Araujo-Soares V, et al. Efficacy and acceptability of very low energy diets in overweight and obese people with type 2 diabetes mellitus: a systematic review with meta-analyses. Diabet Med. 2016;33:580-591.
Steven S, Taylor R. Restoring normoglycaemia by use of a very low calorie diet in long- and short-duration type 2 diabetes. Diabet Med. 2015;32:1149-1155.
Stokes J, Gellatly J, Bower P, et al. Implementing a national diabetes prevention programme in England: lessons learned. BMC Health Serv Res. 2019;19:991.
Boocock RC, Lake AA, Moore HJ, et al. Clinicians' perceived barriers and enablers to the dietary management of adults with type 2 diabetes in primary care: a systematic review. J Hum Nutr Diet. 2021;34(6):1042-1052. doi: 10.1111/jhn.12875
Dunbar JA. Diabetes prevention in Australia: 10 years results and experience. Diabetes Metab J. 2017;41:160-167.
Halley M, Peterse J, Nasrallah C, Szwerinski NK, Romanelli R, Azar KMJ. Barriers and facilitators to real-world implementation of the diabetes prevention program in large healthcare systems: lifestyle coach perspectives. J Gen Intern Med. 2020;35(6):1684-1692. doi: 10.1007/s11606-020-05744-y

Auteurs

Lucia Rehackova (L)

Policy Research Unit Behavioural Science, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Policy Innovation Research Unit, London School of Hygiene and Tropical Medicine, London, UK.

Roy Taylor (R)

Magnetic Resonance Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.

Mike Lean (M)

Human Nutrition, School of Medicine Dentistry and Nursing, University of Glasgow, Glasgow, UK.

Alison Barnes (A)

Human Nutrition Research Centre, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Louise McCombie (L)

Human Nutrition, School of Medicine Dentistry and Nursing, University of Glasgow, Glasgow, UK.

George Thom (G)

Human Nutrition, School of Medicine Dentistry and Nursing, University of Glasgow, Glasgow, UK.

Naomi Brosnahan (N)

Human Nutrition, School of Medicine Dentistry and Nursing, University of Glasgow, Glasgow, UK.

Wilma S Leslie (WS)

Human Nutrition, School of Medicine Dentistry and Nursing, University of Glasgow, Glasgow, UK.

Falko F Sniehotta (FF)

Policy Research Unit Behavioural Science, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Faculty of Behavioural, Management and Social Sciences (BMS), Twente University, Enschede, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH